NCT02377752 2021-02-17A Study of Olaratumab in Japanese Participants With Advanced CancerEli Lilly and CompanyPhase 1 Completed25 enrolled 19 charts
NCT02677116 2020-05-20A Study of Olaratumab Alone and in Combination With Standard Chemotherapies in Children With CancerEli Lilly and CompanyPhase 1 Completed68 enrolled 26 charts